| 引用本文: |
童禧辰,尚春晓,陈文,等.普惠型商业医疗保险的罕见病用药保障现状与趋势分析*[J].中国卫生经济,2023,42(9):36-38.[点击复制] |
Tong Xichen,Shang Chunxiao,Chen Wen,et al.Analysis on the Current Status and Trend of Rare-disease Drugs Security of Inclusive Commercial Medical Insurance[J].CHINESE HEALTH ECONOMICS,2023,42(9):36-38.[点击复制] |
|
| 摘要: |
| 目的：厘清我国普惠型商业医疗保险对罕见病用药保障的现状与发展趋势。方法：系统收集2021—2022年全国各省份实施的普惠型商保方案及其特定药品目录，进行定性描述与定量分析。结果：2021—2022年，保障罕见病用药的普惠型商保方案数量有所增加，普惠型商业医疗保险覆盖的罕见病特药数量也有所增加；2022年，更多普惠型商业医疗保险为罕见病特药单独设置了保障水平，该水平低于一般特药保障。结论：普惠型商业医疗保险对罕见病用药的保障不断优化，但罕见病用药保障水平的提高仍需多层次保障体系中各方共同努力。 |
| 关键词: 普惠型商业医疗保险 罕见病 用药保障 |
| DOI： |
| 投稿时间：2023-06-20 |
| 基金项目:国家社会科学基金重大项目 （20ZDA072） |
|
| Analysis on the Current Status and Trend of Rare-disease Drugs Security of Inclusive Commercial Medical Insurance |
| Tong Xichen,Shang Chunxiao,Chen Wen,Zhang Luying |
| (School of Public Health, Fudan University, Shanghai, 200032 , China) |
| Abstract: |
| Objective: To clarify the current status and development trend of the security of drugs for rare diseases by inclusive commercial medical insurance. Method: Quantitative and qualitative methods were conducted on the inclusive commercial medical in- surance programs and specific drug lists covering various cities all over the country during 2021-2022. Results: From 2021 to 2022, the number of GSP schemes covering medicines for rare diseases increases, and the number of rare disease specialty medicines cov- ered by GSP increases. 2022 sees more GSP schemes setting separate coverage levels for rare disease specialty medicines, which are lower than general specialty medicines coverage. Conclusion: Rare disease drug coverage under universal commercial insurance con- tinues to be optimized, but improving the level of rare disease drug coverage still requires the concerted efforts of all parties in the multi-level coverage system |
| Key words: inclusive commercial insurance rare disease medication assurance |
